In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Reckitt Benckiser Group PLC

http://www.rb.com

Latest From Reckitt Benckiser Group PLC

RB Predicts 'Challenging' Rest Of Year For OTC Business

Reckitt Benckiser is expecting its OTC sales to be hit by a weak cold and flu season this year, as the social distancing measures introduced to quash the COVID-19 outbreak also disrupt the circulation of seasonal illnesses. 

Sales & Earnings OTC Drugs

Indivior Must Disband Suboxone Sales Force, Implement Executive Pay Recoupment Program

$600m settlement with DOJ over Suboxone marketing includes corporate integrity agreement and exclusion of subsidiary from government health programs. Indivior also agrees to pay $10m to FTC and be enjoined from future antitrust violations.

Advertising, Marketing & Sales Legal Issues

People On The Move: Appointments At RB, Angelini And Weleda

Reckitt hires P&G veteran to lead its transformation, while Italy's Angelini and Switzerland's Weleda have new country chiefs.

Appointments Leadership

Nurofen Ad Pulled In NZ For Irresponsible Message During COVID Pandemic

Reckitt Benckiser's TV ad for Nurofen in New Zealand drew numerous complaints for being "socially irresponsible" during the COVID-19 pandemic. 

Ad Complaints Ad Campaigns
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register